<- Back to digest

JAAOS - 2026-10-01 - Journal Article

Medicare Advantage in Total Knee Arthroplasty: No Difference in 1-year Outcomes Among 7,267 Total Knee Arthroplasty Patients.

Jevnikar BE, Elmenawi KA, Jin Y, Khan ST, Pasqualini I, Piuzzi NS, CCARR Corporate Authorship

prospective cohortLOE IIn = 7,2671 year (with 90-day utilization endpoints also captured)

Topics

arthroplasty
PMID: 41468584DOI: 10.5435/JAAOS-D-25-00841View on PubMed ->

Key Takeaway

After multivariable adjustment, Medicare Advantage status was not associated with increased odds of revision surgery (OR 0.85, 95% CI 0.66–1.08) or any other adverse outcome at 1 year among 7,267 primary TKA patients.

Summary Depth

Choose how much analysis to show on this article page.

Summary

This study compared 1-year postoperative outcomes between Medicare Advantage (MA, n=3,293) and Traditional Medicare (TM, n=3,974) patients undergoing primary TKA at a single high-volume academic center from 2016–2023. MA patients had significantly higher baseline social risk (area deprivation index 49.0 vs. 42.0, non-White race 17.7% vs. 10.2%). Unadjusted differences in 90-day ED visits (16.8% vs. 14.6%) and 1-year revision (4.4% vs. 3.5%) favored TM, but all differences were eliminated after multivariable adjustment.

Key Limitation

Single high-volume academic center with uniform care pathways; findings cannot be extrapolated to community or safety-net settings where MA care coordination barriers and resource constraints are most pronounced.

Original Abstract

BACKGROUND

Medicare advantage (MA) enrollment is rising rapidly, now comprising over half of all Medicare beneficiaries. Compared with traditional medicare (TM), MA patients are more likely to be socioeconomically disadvantaged and subject to distinct care coordination barriers, yet few studies have examined how these differences affect postoperative outcomes after total knee arthroplasty (TKA).

METHODS

We analyzed a prospective cohort of 7,267 Medicare beneficiaries who underwent primary TKA at a high-volume academic center between 2016 and 2023. Patients were categorized MA or TM based on insurance status at the time of surgery. Primary outcomes included postoperative healthcare utilization: prolonged length of stay (≥2 days), nonhome discharge, 90-day readmission, 90-day emergency department visit, 1-year revision surgery, and 1-year mortality. Multivariable logistic regression models adjusted for demographic, clinical, and socioeconomic covariates.

RESULTS

Of the cohort, 3,293 (45.3%) were MA and 3,974 (54.7%) were TM. MA patients were more likely to be non-White (17.7% vs. 10.2%, P < 0.001), have higher area deprivation index scores (49.0 vs. 42.0, P < 0.001), and higher smoking rates (6.1% vs. 4.0%, P < 0.001). Unadjusted rates of 90-day emergency department visits (16.8% vs. 14.6%, P = 0.011) and 1-year revision surgery (4.4% vs. 3.5%, P = 0.041) were higher in the MA group. However, after adjustment, MA status was not significantly associated with increased odds of any adverse outcome, including revision surgery (odds ratio, 0.85; 95% confidence interval, 0.66 to 1.08; P = 0.181) or mortality (odds ratio, 0.89; 95% confidence interval, 0.73 to 1.10; P = 0.285).

CONCLUSION

Despite greater baseline social risk, MA patients undergoing TKA at a high-volume academic center experienced comparable short-term outcomes with their TM counterparts. These findings suggest that when standardized care pathways are applied, Medicare subcategory alone does not predict postoperative healthcare utilization. As MA enrollment continues to grow, ensuring equitable outcomes will require adaptation of clinical workflows and research strategies to better reflect the evolving Medicare landscape.